Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.63%
SPX
+0.52%
IXIC
+0.47%
FTSE
-0.43%
N225
0.00%
AXJO
0.00%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Join our newsletter to keep up to date with us!

Latest Yield10 Bioscience News

benzinga.com

Engaging In Insider Activity, Kristin Patrick At Niagen Bioscience Exercises Options Worth $0

3 days ago
benzinga.com

Breaking Update: Wendy Tak Wing YU Engages In Options Exercise At Niagen Bioscience Realizing $0

3 days ago
benzinga.com

Options Exercise Update At Niagen Bioscience: Ann Cohen Engages, Resulting In $0

4 days ago
benzinga.com

Options Exercise Update At Niagen Bioscience: Jeong James Lee Attorney-in-Fact Engages, Resulting In $0

4 days ago
benzinga.com

Steven Rubin At Niagen Bioscience Exercises Options Worth $0

4 days ago
benzinga.com

What's Going On With Regencell Bioscience Stock Today?

Feature Image for interests on Basic Materials, Movers, News, Stock from benzinga.com
14 days ago
prnewswire.com

Nordic Bioscience lance un nouveau test d'Endotrophin

Feature Image for interests on Basic Materials, Health Care & Hospitals, Medical Pharmaceuticals, New Products & Services from prnewswire.com
about 2 months ago
prnewswire.com

Nordic Bioscience bringt neuen Endotrophin-Test auf den Markt

Feature Image for interests on Basic Materials, Health Care & Hospitals, Medical Pharmaceuticals, New Products & Services from prnewswire.com
about 2 months ago
prnewswire.com

Nordic Bioscience launches novel Endotrophin assay

Feature Image for interests on Basic Materials, Health Care & Hospitals, Medical Pharmaceuticals, New Products & Services from prnewswire.com
about 2 months ago
prnewswire.com

Kaerus Bioscience's lead candidate KER-0193 granted Orphan Drug Designation and Rare Pediatric Drug Designation by U.S. FDA for treatment of Fragile X syndrome (FXS)

about 2 months ago
Stocks
Health Care
ytenq
Yield10 Bioscience
YTENQ
0.00 (0.00%)
0.0001
USD
At close at Jun 30, 20:41 UTC
Summary
News
Signals
Benchmarks
Financials

Latest Cashu News

publisher logo
Cashu

Yield10 Bioscience: Insider Activity Indicates Strong Growth Confidence and Market Potential

3 days ago
publisher logo
Cashu

Yield10 Bioscience Positions for Growth Amid Agricultural Biotechnology Sector Evolution

11 days ago
publisher logo
Cashu

Yield10 Bioscience: Leading Sustainable Innovations in Agricultural Biotechnology

13 days ago